Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BPMC

Blueprint Medicines

$57.43

0.66 (1.16%)

18:29
12/02/18
12/02
18:29
12/02/18
18:29
Hot Stocks
Blueprint Medicines announces updated results from ongoing EXPLORER trial »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

DCPH

Deciphera

$22.61

1.99 (9.65%)

, BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

08:42
11/16/18
11/16
08:42
11/16/18
08:42
Recommendations
Deciphera, Blueprint Medicines analyst commentary at Leerink »

Deciphera price target…

DCPH

Deciphera

$22.61

1.99 (9.65%)

BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Blueprint Medicines analyst commentary at Wedbush »

Blueprint Medicines data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

DCPH

Deciphera

$22.50

1.88 (9.12%)

, BPMC

Blueprint Medicines

$54.16

-2.22 (-3.94%)

10:32
11/15/18
11/15
10:32
11/15/18
10:32
Recommendations
Deciphera, Blueprint Medicines analyst commentary at Piper Jaffray »

Deciphera remains well…

DCPH

Deciphera

$22.50

1.88 (9.12%)

BPMC

Blueprint Medicines

$54.16

-2.22 (-3.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

BPMC

Blueprint Medicines

$56.38

-3.89 (-6.45%)

07:25
11/15/18
11/15
07:25
11/15/18
07:25
Conference/Events
Blueprint Medicines to hold a conference call »

Management presents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BPMC

Blueprint Medicines

$56.38

-3.89 (-6.45%)

07:05
11/15/18
11/15
07:05
11/15/18
07:05
Hot Stocks
Blueprint Medicines updates avapritinib trial results for stomach tumors »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BPMC

Blueprint Medicines

$56.38

-3.89 (-6.45%)

04:55
11/15/18
11/15
04:55
11/15/18
04:55
Conference/Events
Blueprint Medicines to hold a conference call »

Management presents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

BPMC

Blueprint Medicines

$60.22

-3.1 (-4.90%)

16:15
11/11/18
11/11
16:15
11/11/18
16:15
Conference/Events
Blueprint Medicines to hold a conference call »

Management presents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

Over a month ago
BPMC

Blueprint Medicines

$68.18

6.53 (10.59%)

04:55
11/08/18
11/08
04:55
11/08/18
04:55
Conference/Events
Blueprint Medicines management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

BPMC

Blueprint Medicines

$61.65

-1.84 (-2.90%)

05:58
11/07/18
11/07
05:58
11/07/18
05:58
Conference/Events
Blueprint Medicines management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.